Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation

Autor: Marco Alings, Frans H Rutten, Bart van den Bemt, Ewoud J Van Dijk, Suzanne C Cannegieter, Menno V Huisman, Michiel Rienstra, Frederikus A Klok, Geert-Jan Geersing, Marc A Brouwer, Robert G Tieleman, Gordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, Anouk P van Alem, Lucas VA Boersma, Hugo ten Cate, Charles JHJ Kirchhof, Harry JGM Crijns, Arif Elvan, Isabelle C van Gelder, Joris R de Groot, Frank R den Hartog, Jonas SSG de Jong, Sylvie de Jong, Timo Lenderink, Justin G Luermans, Joan G Meeder, Ron Pisters, Peter Polak, Frans Smeets, Giovanni JM Tahapary, Luc Theunissen, Serge A Trines, Pepijn van der Voort, Martin EW Hemels

Publikováno v: BMJ Open, Vol 10, Iss 8 (2020)

Introduction Anticoagulation therapy is pivotal in the management of stroke prevention in atrial fibrillation (AF). Prospective registries, containing longitudinal data are lacking with detailed information on anticoagulant therapy, treatment adheren

Externí odkaz: https://doaj.org/article/36dfb623da8849bd801197b90789f8e0

Effect of Using the HEART Score in Patients With Chest Pain in the Emergency Department: A Stepped-Wedge, Cluster Randomized Trial

Autor: Bernard J.W.M. Rensing, Hendrik Koffijberg, Roland R.J. van Kimmenade, Ghizelda R. Lagerweij, Rolf F. Veldkamp, Maarten J. Cramer, Madelon van den Heuvel, Johannes B. Reitsma, A. Jacob Six, Judith M. Poldervaart, Barbra E. Backus, Nicolette M.S.K.J. Ernst, Clara E.E. van Ofwegen-Hanekamp, Arno W. Hoes, Herman F.J. Mannaerts, Ineke M.C. Dekker, Mohamed el Farissi, Pieter A. Doevendans, Marcel A.J. Landman, Jan Melle van Dantzig, Jeroen J.J. Bucx, Yolande Appelman, Maarten W. J. van Hessen, Monique E. ten Haaf, Frank R. den Hartog, Luc Cozijnsen, Thomas Oosterhof, Eugene M. Buijs

Publikováno v: Poldervaart, J M, Reitsma, J B, Backus, B E, Koffijberg, H, Veldkamp, R F, Ten Haaf, M E, Appelman, Y, Mannaerts, H F J, Van Dantzig, J M, Van Den Heuvel, M, El Farissi, M, Rensing, B J W M, Ernst, N M S K J, Dekker, I M C, Den Hartog, F R, Oosterhof, T, Lagerweij, G R, Buijs, E M, Van Hessen, M W J, Landman, M A J, Van Kimmenade, R R J, Cozijnsen, L, Bucx, J J J, Van Ofwegen-Hanekamp, C E E, Cramer, M J, Six, A J, Doevendans, P A & Hoes, A W 2017, ' Effect of using the HEART score in patients with chest pain in the emergency department : A Stepped-wedge, cluster randomized trial ', Annals of Internal Medicine, vol. 166, no. 10, pp. 689-697 . https://doi.org/10.7326/M16-1600
Annals of Internal Medicine, 166(10), 689. American College of Physicians
Annals of Internal Medicine, 166(10), 689-697. American College of Physicians
Annals of Internal Medicine C.2, 166, 689-697
Annals of Internal Medicine C.2, 166, 10, pp. 689-697

Item does not contain fulltext Background: The HEART (History, Electrocardiogram, Age, Risk factors, and initial Troponin) score is an easy-to-apply instrument to stratify patients with chest pain according to their short-term risk for major adverse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6543c535e51c3ba87cdb86940bd3c0ce
https://doi.org/10.7326/M16-1600

A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: a randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease

Autor: Frank R den Hartog, Mieke D. Trip, Huub J.A.M Penn, John J.P. Kastelein, Marjel van Dam, Rudolf J.A Buirma, Hans A Kragten

Publikováno v: Clinical therapeutics, 23(3), 467-478. Excerpta Medica

BACKGROUND: Use of cholesterol-lowering regimens has been shown to reduce the risk of coronary heart disease (CHD), both in primary and secondary prevention. However, there have been few studies of the relative benefits and risks of the various chole

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6083f049a13de59cfb351bc7af56413
https://doi.org/10.1016/s0149-2918(01)80050-3

Estatinas para el síndrome coronario agudo

Autor: Anho H. Liem, Furio Colivicchi, Edward J Mills, Neera Bhatnagar, Alain J Nordmann, Petr Ostadal, Hartog F. Den, S. Macin, H. Bugheb, E. C. Mills, G. Schwartz, Frank R. den Hartog, Stella M. Macín, James A. de Lemos, A. Liem, N. Vale, Noah Vale, N. Bhatnagar, P. Ostadal, M. Briel, Matthias Briel, A. Nordmann, J. De Lemos, F. Colivicchi, Gregory G. Schwartz, Heiner C. Bucher

Publikováno v: Revista Médica Clínica Las Condes, Vol 23, Iss 6, Pp 782-783 (2012)

Resumen Antecedentes El periodo inmediato despues del inicio del sindrome coronario agudo (SCA) representa un estadio critico de la cardiopatia coronaria con un alto riesgo de eventos recurrentes y muertes. En los pacientes que presentan SCA los efec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc9cd570a58da7f354003500dc9fd6d

Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes.

Autor: Briel, Matthias, Schwartz, Gregory G., Thompson, Peter L., de Lemos, James A., Blazing, Michael A., van Es, Gerrit-Anne, Kavikcioglu, Meral, Arntz, Hans-Richard, den Hartog, Frank R., Veeger, J. G. M., Colivicchi, Furio, Dupuis, Jocelyn, Okazaki, Shinya, Wright, Scott, Bucher, Heiner C., Nordmann, Alain J.

Publikováno v: JAMA: Journal of the American Medical Association; 5/3/2006, Vol. 295 Issue 17, p2046-2056, 11p, 1 Diagram, 7 Charts, 4 Graphs